25
42
Growth Score 25 in past quarter
-9 pts
Heat Score 42 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
246578
Envision Pharma Group is an innovative scientific communications and technology company focused on the life science industry.
- Brian Hepburn: Founder, Owner & Executive Chairman
- Adam Deutsch: General CounselPast Role: ConvaTec, Executive Vice President of General Counsel & Corporate Development
About the Company
The Envision Pharma Group is an innovative scientific communications and technology company focused on the life science industry that works with clients, authors, and the medical publishing community to develop and execute evidence-based communication programs in a transparent and compliant manner. Envision supports clients across the product life
cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions
